Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002541038 | SCV003613872 | uncertain significance | Inborn genetic diseases | 2022-02-03 | criteria provided, single submitter | clinical testing | The c.1150C>T (p.R384W) alteration is located in exon 8 (coding exon 8) of the GRIA2 gene. This alteration results from a C to T substitution at nucleotide position 1150, causing the arginine (R) at amino acid position 384 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692722 | SCV005190323 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics Laboratory, |
RCV001771810 | SCV002011747 | uncertain significance | Neurodevelopmental disorder with language impairment and behavioral abnormalities | 2021-06-17 | no assertion criteria provided | clinical testing |